Related Experiment Video
Updated: Jun 19, 2026

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
Published on: April 28, 2022
Encapsulating peritoneal sclerosis: importance to the hemodialysis practitioner
Jeffrey Perl1, Joanne M Bargman, Christopher T Chan
1Department of Nephrology, University Health Network, Toronto, Ontario, Canada.
Encapsulating peritoneal sclerosis (EPS) is a severe complication of peritoneal dialysis (PD). Early diagnosis and treatment, including immunosuppression and nutritional support, are crucial for managing this condition in hemodialysis patients.
Area of Science:
- Nephrology
- Gastroenterology
Background:
- Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication of long-term peritoneal dialysis (PD).
- It involves peritoneal membrane inflammation, fibrosis, and intestinal encapsulation, leading to poor prognosis.
Observation:
- EPS diagnosis often occurs after transfer to hemodialysis (HD).
- Patients may present with ascites and recurrent small bowel obstruction.
Findings:
- Risk factors for EPS are not fully understood, but longer PD duration increases frequency.
- Early immunosuppressive therapy is key; parenteral nutrition and surgery may be needed for obstruction.
Implications:
- HD practitioners must maintain a high index of suspicion for EPS in patients with GI symptoms and prior PD history.
- Prompt diagnosis and treatment initiation are essential for improving outcomes in EPS patients.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis I: Introduction and Procedure
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications

